Template:Cefuroxime axetil: Difference between revisions

Revision as of 05:01, 6 January 2014

@@ Line 14: / Line 14: @@
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil contraindications|Contraindications]]
 |-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime  axetil warnings and precautions|Warnings and Precautions]]
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil warnings and precautions|Warnings and Precautions]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil adverse reactions|Adverse Reactions]]
@@ Line 24: / Line 24: @@
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil how supplied|How Supplied]]
 |-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime clinical studeis |Clinical Studies ]]
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime clinical studies |Clinical Studies ]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime direction for use|Direction For Use]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime labels and packages|Labels and Packages]]
 |-
 |}